One of these subtypes is triple-negative breast cancer (TNBC), which is negative in estrogen receptor (ER) and progesterone receptor (PR) and also negative in human epidermal growth factor receptor 2 (HER2) overexpression3. Here, ERBB2 is linked to triple-negative breast carcinoma.